Quick verdict
The strongest FDA-approved weight-loss injection on the market. Best for: Adults with BMI ≥30, or ≥27 with weight-related conditions, seeking maximum weight loss.
Official site: Zepbound.com · FDA prescribing label (PDF) · Savings program
Pros
- Highest average weight loss in trials of any approved drug
- Dual GLP-1/GIP receptor action
- FDA-approved specifically for chronic weight management
- Lilly Direct self-pay vials reduce out-of-pocket cost
Cons
- Expensive without insurance coverage
- Frequent supply constraints
- GI side effects common in titration
How Zepbound works
Zepbound contains tirzepatide, a dual receptor agonist that activates both glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors. It mimics gut hormones released after eating, producing three core effects (see our deeper explainer on how GLP-1s work):
- Slowed gastric emptying — food stays in your stomach longer, increasing fullness.
- Reduced appetite signaling — the drug acts on the hypothalamus to suppress hunger and food noise.
- Glucose-dependent insulin release — pancreatic beta cells release insulin only when blood sugar is elevated, lowering A1c without typical hypoglycemia.
The additional GIP activity appears to enhance weight loss and improve insulin sensitivity beyond what GLP-1 alone achieves — likely why tirzepatide outperforms semaglutide in head-to-head trials.
Who Zepbound is for
Adults with BMI ≥30, or ≥27 with weight-related conditions, seeking maximum weight loss.
FDA-approved indications:
- Chronic weight management
- Obstructive sleep apnea (in obesity)
Who should avoid it
- Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome
- History of pancreatitis
- Severe gastroparesis or inflammatory bowel disease
- Pregnancy, planning pregnancy within 2 months, or breastfeeding
- Active gallbladder disease (relative contraindication)
See our full safety guide for context on each contraindication.
How to take Zepbound
Starting dose: 2.5 mg subcutaneously once weekly
Maximum dose: 15 mg once weekly
- Inject subcutaneously in the abdomen, thigh, or upper arm.
- Once per week, same day each week, with or without food.
- Rotate injection sites to prevent skin irritation.
- Doses are titrated up monthly to minimize nausea — do not skip ahead.
Side effects
Common (≥5% of users):
- Nausea
- Diarrhea
- Constipation
- Vomiting
- Fatigue
- Injection-site reaction
Serious warnings:
- Boxed warning: thyroid C-cell tumors (rodents)
- Pancreatitis
- Gallbladder disease
- Hypoglycemia (with insulin/sulfonylureas)
Most GI side effects appear during dose escalation and ease within 2–4 weeks. Eating smaller meals, avoiding greasy foods, and staying hydrated helps — our side-effect management guide covers practical tactics in detail. Persistent severe abdominal pain warrants immediate medical evaluation to rule out pancreatitis or gallbladder disease.
Where to get Zepbound
- Primary care or endocrinology: The most reliable route — your clinician handles prior authorization and monitoring.
- Telehealth platforms: Services like Ro, WW Clinic (Sequence), Form Health, and Hims/Hers prescribe FDA-approved GLP-1s after a video evaluation. Verify they prescribe the brand name, not just compounded versions.
- Direct-to-consumer: Lilly Direct offers self-pay vials of Zepbound at reduced cash prices. See the official Zepbound savings page.
- Avoid: Research peptides, unverified compounding pharmacies, and overseas online pharmacies. The FDA has documented counterfeit semaglutide circulating in the US supply chain.
Step-by-step pathways are covered in our guide to getting a GLP-1 prescription.
Cost
List price is approximately ~$1,086/mo. With commercial insurance and a savings card, many patients pay $0–$25/month. Without insurance, expect $500–$1,400/month depending on the program. Compare cash prices on GoodRx or Cost Plus Drugs.
Key evidence
The pivotal trial for Zepbound is SURMOUNT-1 (NEJM, 2022): Tirzepatide produced up to 22.5% mean weight loss at 72 weeks in adults with obesity.
- FDA prescribing information (PDF) — full label, including boxed warning and trial summaries.
- ClinicalTrials.gov — active and completed studies of tirzepatide
- PubMed — peer-reviewed literature on tirzepatide
- The Obesity Society — clinical management of obesity
Frequently asked questions
How quickly does Zepbound work?
Most people notice reduced appetite within 1–2 weeks of starting Zepbound. Meaningful weight or A1c changes typically appear after 8–12 weeks at a therapeutic dose, with maximum effects between 6 and 18 months.
Will I regain weight if I stop Zepbound?
Clinical trials (STEP, SURMOUNT) show that most people regain a significant portion of lost weight within a year of stopping a GLP-1. These medications are generally considered long-term therapies, similar to blood pressure or cholesterol drugs.
Can I drink alcohol on Zepbound?
There is no absolute contraindication, but alcohol can worsen nausea and increase the risk of pancreatitis and hypoglycemia (especially if combined with insulin or sulfonylureas). Many patients report decreased desire for alcohol on GLP-1s.
Is Zepbound covered by insurance?
Coverage for weight loss is inconsistent. Some commercial plans cover it with a BMI requirement; Medicare currently does not cover GLP-1s purely for obesity. Manufacturer savings programs and self-pay options can reduce cost.
What happens if I miss a dose?
Take the missed dose within 5 days. If more than 5 days have passed, skip it and take the next scheduled dose. Do not double up.
Can I use Zepbound during pregnancy?
No. GLP-1 medications should be stopped at least 2 months before a planned pregnancy. They are not recommended in pregnancy or breastfeeding due to limited safety data.
Compare Zepbound to alternatives
Head-to-head guides: Zepbound vs Wegovy. Or see the full side-by-side comparison table.
Wegovy
semaglutide
Semaglutide for weight loss — the household name with cardiovascular data.
Mounjaro
tirzepatide
Tirzepatide for type 2 diabetes — and the most powerful A1c reducer available.
Ozempic
semaglutide
The semaglutide brand that started the GLP-1 revolution.
Further reading
- What are GLP-1 medications? — class overview
- How GLP-1s work in the body
- Are GLP-1s safe? — risks and contraindications
- Managing GLP-1 side effects
- How to get a prescription